Madam — The SARS-CoV-2 novel coronavirus has precipitated the world into a state of emergency [1,2]. Although the index case was acquired by zoonotic exposure [3], the combined dynamics of rapid human-to-human transmission [4], incubation period dissemination [5], and potential faeco-oral spread [6,7] render cancer patients vulnerable, owing to immunosuppression due to the primary disease or secondary to treatment [8].
India expects an exponential increase in the number of cases in the coming weeks. This was estimated at 300 million in the absence of external interventions [9] and is worsened by low testing rates [10]. To put numbers into perspective, India has an annual incidence of 1.2 million cancer patients, two-thirds of whom require radiotherapy [11]. A shortfall of radiotherapy units, a low clinician to patient ratio, and inadequate financial coverage; a prototype unique to lower–middle-income countries (LMICs) and low-income countries (LICs) already contributes to long waiting lists and patients foregoing treatment with subsequent disease progression [12]. These factors combined with a high population density can result in increased SARS-CoV-2 transmission and mortality in LMICs/LICs, and cautious policymaking is warranted.
Fractionated radiotherapy treatments typically last over a few weeks and stopping or delaying treatment during its course correlates with poor local control and adverse survival. The general measures should include but not be limited to prioritising patients, consideration of induction chemotherapy instead of radiotherapy when there is an evidence-driven choice (e.g. hypopharyngeal and laryngeal cancers), judicious use of advanced radiotherapy techniques that require more time for planning and verification, the use of hypofractionation, and proper administrative handling of staff [13]. Ideally, one needs to achieve an ‘oncological triage’, whereby cancer progression due to logistic delay is balanced by mitigating SARS-CoV-2 transmission by social distancing. Finally, the appearance of pseudoscientific quackery in times of a global pandemic is deeply disturbing [14,15] and should be dealt with sternly. We are already at the eleventh hour and must act now in unison to achieve the best possible outcomes for our patients.
Conflicts of Interest
The author declares no conflict of interest.
References
- 1.Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Johns Hopkins Coronavirus Resource Centre https://coronavirus.jhu.edu/map.html
- 3.Zhou P., Yang X., Wang X., Hu B., Zhang L., Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi: 10.1056/NEJMoa2001316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971. doi: 10.1056/NEJMc2001468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zhang W., Du R., Li B., Zheng X., Yang X., Hu B. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389. doi: 10.1080/22221751.2020.1729071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020 doi: 10.1016/S2468-1253(20)30083-2. pii:S2468–1253(20)30083-2, [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Liang W., Guan W., Chen R., Wang W., Li J., Xu K. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi: 10.1016/S1470-2045(20)30096-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ganguly S. India must prepare for a tsunami of coronavirus cases. https://www.bbc.com/news/av/world-asia-india-51962813/india-must-prepare-for-a-tsunami-of-coronavirus-cases
- 10.Li R., Pei S., Chen B., Song Y., Zhang T., Wang W. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) Science. 2020 doi: 10.1126/science.abb3221. pii:eabb3221, [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Munshi A., Ganesh T., Mohanti B. Radiotherapy in India: history, current scenario and proposed solutions. Indian J Cancer. 2019;56:359–363. doi: 10.4103/ijc.IJC_82_19. [DOI] [PubMed] [Google Scholar]
- 12.Murphy A., Palafox B., Walli-Attaei M., Powell-Jackson T., Rangarajan S., Alhabib K. The household economic burden of non-communicable diseases in 18 countries. BMJ Glob Heal. 2020;5(2) doi: 10.1136/bmjgh-2019-002040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.ESTRO Newsroom Radiotherapy in a time of crisis. https://www.estro.org/About/Newsroom/News/Radiotherapy-in-a-time-of-crisis ESTRO Presidents’ statement.
- 14.Siddiqui D. Hindu group offers cow urine in a bid to ward off coronavirus. https://www.reuters.com/article/us-health-coronavirus-india-cow-urine-pa/hindu-group-offers-cow-urine-in-a-bid-to-ward-off-coronavirus-idUSKBN2110D5
- 15.Reality Check Team Coronavirus: is drinking cow urine any help? https://www.bbc.com/news/world-asia-india-51910099